Dr Jessica Garner considers some possible causes of chronic cough and describes the tests used to diagnose or eliminate a range of conditions

garner jessica edited

Dr Jessica Garner

20160729 independent content logo with text (rgb)

Read this article to learn more about:

  • recognising the red flags associated with chronic cough
  • identifying the cause of chronic cough based on a patient’s presenting symptoms, examination, and diagnostic tests
  • treating and managing the different conditions associated with chronic cough.

After reading this article, ‘Test and reflect’ on your updated knowledge with our multiple-choice questions. Earn 0.5 CPD credits.

Chronic cough is one of the most common presentations seen in general practice, with the condition affecting between 10% and 20% of the population.1,2 Chronic cough is defined as a cough lasting longer than 8 weeks and it can cause significant impairment to quality of life.3 There are numerous causes of chronic cough and a clear history is vital in guiding further management. Important risk factors include smoking and a history of atopy. Drug history is also important since a number of common drugs, such as angiotensin converting enzyme inhibitors, can precipitate cough.2 Occupational and travel history are also important and should not be neglected.

Given the vast number of patients who present each year with cough symptoms, it is important to be able to differentiate a cough due to serious underlying pathology from more benign disease. Box 1 lists ‘red flags’ that would warrant prompt investigation and appropriate management.

Box 1: Red flag symptoms in chronic cough

  • Excessive sputum production (bronchiectasis)4
  • Systemic symptoms e.g. fever, sweats, and weight loss (lung carcinoma, or TB)2,4
  • Haemoptysis (lung carcinoma or TB)2,4
  • Significant associated dyspnoea (heart failure, COPD, pulmonary fibrosis, or inhaled foreign body).2,4,5


Case 1

A 37-year-old woman presents with a 4-month history of a dry cough. The cough is worse at night, often causing her to wake up, and is more noticeable in cold weather. She has a history of hayfever and her brother had childhood asthma. She is a keen runner and has noticed that over the last few months she has found it more difficult to train than usual. She works as a high school teacher and is not on any regular medication. She has no known allergies, is a non-smoker, and has no pets. On examination she is well and her chest is clear. A peak flow reading gives a result of 65% of predicted value.


Given the patient’s history, a diagnosis of asthma is high on the list of possible diagnoses. NICE Guideline (NG) 80 on Asthma: diagnosis, monitoring and chronic asthma management6 recommends that all patients with suspected asthma should be offered objective testing for the disease, rather than relying purely on a convincing history. Fractional exhaled nitric oxide (FeNO) testing should be carried out as first-line diagnostic testing, in conjunction with spirometry (see Box 2).6

Should tests result in an uncertain diagnosis, a 2–4-week period of serial measurement of peak flow may be helpful. Variability of more than 20% is regarded as diagnostic. Should a diagnosis of asthma still be in doubt, despite a convincing history and supportive clinical examination, direct bronchial challenge testing with histamine or methacholine can also be used to test for airway hyperactivity. Should these results be negative or inconclusive, an alternative diagnosis should be considered or the patient referred to secondary care. Interestingly, if direct bronchial challenge testing is unavailable, treating the patient as if they had asthma and monitoring improvement is appropriate.6

Box 2: Diagnosing asthma in adults aged 17 and over6

Diagnose asthma in adults (aged 17 and over) if they have symptoms suggestive of asthma and:

  • a FeNO level of 40 ppb or more with either positive bronchodilator reversibility or positive peak flow variability or bronchial hyperreactivity, or
  • a FeNO level between 25 and 39 ppb and a positive bronchial challenge test, or
  • positive bronchodilator reversibility and positive peak flow variability irrespective of FeNO level.

© NICE 2017 Asthma: diagnosis, monitoring and chronic asthma management. Available from www.nice.org.uk/ng80 All rights reserved. Subject to Notice of rights. NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication. See www.nice.org.uk/re-using-our-content/uk-open-content-licence for further details.


Given that the patient is having persistent symptoms and waking up at night several times a week, it is reasonable to start her on a low-dose inhaled corticosteroid (ICS) along with a short-acting beta2 -agonist (SABA).6 A review 4–8 weeks later would be appropriate to monitor symptoms. Adding a leukotriene receptor antagonist (LTRA), followed by the introduction of a long-acting beta2 -agonist (LABA), are the next appropriate steps. Should symptom control be difficult to achieve on low-dose ICS plus a LTRA and/or a LABA, the dose of ICS can be carefully titrated upwards.6


The patient’s FeNO and spirometry tests confirmed a diagnosis of asthma. She was treated with a low-dose ICS and an as-required short-acting beta2 -agonist. Within 4 weeks her symptoms had markedly improved. She only required salbutamol when running in cold weather, and her nocturnal cough had completely gone. She attends for asthma reviews regularly and is aware of when to seek help should her symptoms deteriorate.

Case 2

A 48-year-old man presents to the surgery with a 9-week history of a dry cough. He has noticed that the cough is worse after eating, but can occur at any time of the day. He spent the weekend doing DIY which required much bending over, and his cough became much more noticeable. He describes mild dyspepsia after eating, which started approximately 4 months ago. Examination is unremarkable other than mild epigastric tenderness on palpation and a BMI of 38 kg/m2.


Gastro-oesophageal reflux disease (GORD) is a well-recognised cause of chronic cough. Although other symptoms of GORD may be present, these may be mild or even absent in up to 75% of cases.7 The mechanisms behind GORD-induced cough are thought to be a result of either microaspiration of gastric contents and/or a vagally mediated oesophageal-tracheobronchial reflex.7,8 Food intake, as well as a number of medications (such as non-steroidal anti-inflammatory drugs and theophylline), can aggravate GORD, as can posture including lying supine.7


Given the clinical suspicion of GORD, in the absence of any red flag symptoms, an initial 4-week course of a proton pump inhibitor (PPI) can be offered.9 Lifestyle advice regarding weight loss is also appropriate for patients with a BMI over 25 kg/m2.9 If symptoms persist, the patient should be tested for Helicobacter pylori infection with a breath test or a stool antigen test, after a 2-week washout period from the PPI.9


The patient returned for a review appointment 1 month later and reported that his cough had improved significantly. He still experienced a mild cough after heavy meals but otherwise felt much better. He had intentionally lost half a stone in weight and aimed to continue his healthy lifestyle. Because of the ongoing presence of mild symptoms, he was tested for H. pylori; test results were positive so triple therapy (a PPI, amoxicillin, and either clarithromycin or metronidazole9) was prescribed. Following treatment his symptoms resolved.

Case 3

A 39-year-old IT consultant attends with an irritating cough, which has been present on and off for 4 months. For the past 6 weeks it has been occurring on a daily basis and he is concerned he may have an underlying serious pathology. On further questioning, the cough is largely non-productive other than first thing in the morning when he expectorates sputum. His partner has noticed that he appears to be constantly clearing his throat and he has noticed the sensation of something dripping down the back of his throat. The symptoms started after a cold but have persisted since then. He is an ex-smoker, having stopped 6 years ago. He drinks moderate amounts of alcohol and has mild hay fever.


This patient’s symptoms are characteristic of postnasal drip (PND). Postnasal drip, or upper airway cough syndrome as it is also known, is the drainage of secretions from the nose or paranasal sinuses into the pharynx. Multiple studies have suggested that it is the most common cause for a chronic cough.10 Postnasal drip is largely diagnosed by a typical history of the sensation of having something drip down into the throat, nasal discharge, frequent throat clearing, and cough;10 however, it can be diagnostically challenging as there are no objective tests for it and no way to quantify the amount of PND.

The differential diagnoses of PND include all other causes of rhinitis, such as allergic rhinitis, bacterial sinusitis, allergic fungal sinusitis, rhinitis due to anatomic sinonasal abnormalities, rhinitis due to physical or chemical irritants, occupational rhinitis, rhinitis medicamentosa, and rhinitis of pregnancy. A careful history can help differentiate between these various aetiologies.11,12 The issues of PND are further complicated by the fact that GORD can often co-exist with or mimic PND.12

In this case a full examination would be advised. There may be a nasal quality to the voice because of concomitant nasal blockage and congestion, and there may be hoarseness of the voice. Physical examination of the pharynx is often unremarkable, although a ‘cobblestoning’ appearance of the mucosa and draining secretions may be observed.13 Given the patient’s history of smoking and presence of chronic cough, a baseline chest radiograph would be recommended as per British Thoracic Society guidance.2


Treatment of postnasal drip with a trial of topical corticosteroids is not only therapeutic but, given the difficulties in confirming the syndrome, can be of diagnostic importance. The patient should be warned that resolution of symptoms can take several weeks and occasionally months.12 Anecdotally, many clinicians will try a number of topical corticosteroids should the first-line option fail to improve symptoms. If there is a history of potential allergy, non-sedating antihistamines can be used in addition to a topical corticosteroid.12 Care should be taken with decongestants because of the risk of rebound symptoms and rhinitis medicamentosa with prolonged use.14


The patient was given 1-month trial of a low-dose over-the-counter topical steroid. He presented 4 weeks later complaining that his symptoms had failed to improve. He was switched to an alternative nasal spray and good compliance was urged. He presented 6 weeks later delighted that his symptoms had settled and both the cough and clearing of his throat had improved. He continued the topical treatment for a total of 3 months before ceasing medication altogether.

Case 4

A 72-year-old woman presents with a 6-month history of chronic dry cough and increasing breathlessness. She has been treated periodically for chest infections over the past few months. Her breathlessness is beginning to make walking upstairs or on an incline difficult. She does not think she has lost any weight and is not on any regular medications. She has never smoked and is a retired GP receptionist. On examination she has bibasal inspiratory crackles. A chest X-ray is arranged, which is abnormal.


This woman may have underlying pulmonary fibrosis. Pulmonary fibrosis may be secondary to a wide range of diseases; however, one of the most common types is idiopathic which affects approximately 10 per 100,000 people in the UK each year.15,16 Idiopathic pulmonary fibrosis rarely affects people under the age of 45 years and typically presents with breathlessness on exertion, a dry cough, bilateral inspiratory crackles, and clubbing of the fingers. Patients can also exhibit non-specific constitutional symptoms such as myalgia, fatigue, or weight loss. In the later stages of disease, cyanosis and features of right heart failure commonly occur.17 Given this patient’s history and abnormal chest radiograph, a high-resolution computed tomography of her chest is arranged, revealing a typical honeycombing appearance typical of idiopathic pulmonary fibrosis.18 She has baseline spirometry at the practice, which reveals a restrictive pattern, and so is referred to the respiratory multidisciplinary team.


Following the patient’s diagnosis, her future management and prognosis should be sensitively discussed. It is important to explain that, other than lung transplantation, there is no cure for the disease and medication is often ineffective. The median survival for idiopathic pulmonary fibrosis in the UK is approximately 3 years, although up to 20% of people survive for 5 years or more. For this reason good palliative care, even at an early stage, is vital in the management of pulmonary fibrosis.19 The respiratory team arranged for this patient to start pulmonary rehabilitation with regular review on a 6-monthly basis.20


About 1 year after the patient’s diagnosis her health started to deteriorate more rapidly and her spirometry and gas exchange dropped. Home oxygen was initiated and a sensitive discussion about the poor outcomes associated with both mechanical ventilation and resuscitation was had with the patient and her family. She continued to decline rapidly and full palliative care support was provided. She died at home 6 months later.


Chronic cough is a common symptom encountered in general practice. A full history and examination will help to identify the possible causes of cough. Further investigations in the form of lung function tests, testing for the presence of H pylori, chest radiography, and trials of medicines such as PPIs and topical corticosteroids are used to confirm the diagnosis. Treatment and management can be instigated in primary care but patients may need referral to secondary care if test results are inconclusive or if diagnosis reveals conditions such as idiopathic pulmonary fibrosis, which require specialist management.

Dr Jessica Garner

GP, Worcester


  1. Song W, Chang Y, Faruqi S et al. Defining chronic cough: a systematic review of the epidemiological literature. Allergy Asthma Immunol Res 2016; 8 (2): 146–155.
  2. Morice A, McGarvey L, Pavord I. BTS Guidelines. Recommendations for the management of cough in adults. Thorax 2006; 61 (Suppl I): i1–i24.
  3. Gibson P, Wang G, McGarvey L et al. Treatment of unexplained chronic cough: CHEST Guideline and Expert Panel Report. Chest 2016; 149 (1): 27–44.
  4. Barraclough K. Chronic cough in adults. BMJ 2009; 338: 1267–1269.
  5. Bain A, Barthos A, Hoffstein V, Batt J. Foreign-body aspiration in the adult: presentation and management. Can Respir J 2013; 20 (6): e98–e99.
  6. NICE. Asthma: diagnosis, monitoring and chronic asthma management. NICE Guideline 80. NICE, 2017. Available at: www.nice.org.uk/ng80
  7. Fontana G, Pistolesi M. Cough. 3: chronic cough and gastro-oesophageal reflux. Thorax 2003; 58 (12): 1092–1095.
  8. Sekizawa S, Ishikawa T, Sant’Ambrogio F, Sant’Ambrogio G. Vagal esophageal receptors in anesthetized dogs: mechanical and chemical responsiveness. J Appl Physiol 1999; 86 (4): 1231–1235.
  9. NICE. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. Clinical Guideline 184. NICE, 2014 (last updated 2014). Available at: www.nice.org.uk/cg184
  10. Pratter M. Chronic upper airway cough syndrome secondary to rhinosinus diseases (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest 2006; 129 (1 Suppl): 63S–71S.
  11. Quillen D, Feller D. Diagnosing rhinitis: allergic vs nonallergic. Am Family Physician 2006; 73 (9): 1583–1590.
  12. Sylvester D, Karkos P, Vaughan C et al. Chronic cough, reflux, postnasal drip syndrome, and the otolaryngologist. Int J Otolaryngol 2012; 564852.
  13. Chung K, Mazzone S. Postnasal drip (rhinosinusitis, upper airway cough syndrome). In: Brodus V, Mason R, Ernst J et al. Murray and Nadel’s textbook of respiratory medicine. 6th edition. Philadephia: Elsevier, 2016: 497–514.
  14. Pinto J, Jeswani S. Rhinitis in the geriatric population. Allergy Asthma Clin Immunol 2010; 6 (1): 10.
  15. British Lung Foundation website. Idiopathic pulmonary fibrosis statistics. www.blf.org.uk/support-for-you/idiopathic-pulmonary-fibrosis-ipf/statistics (accessed 1 March 2018).
  16. Wilson M, Wynn T. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunology. 2009; 2 (2): 103–121.
  17. Kim D, Collard H, King T. Classification and natural history of the idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006; 3 (4): 285–292.
  18. Devaraj A. Imaging: how to recognise idiopathic pulmonary fibrosis. Eur Respir Rev 2014; 23 (132): 215–219.
  19. NICE. Idiopathic pulmonary fibrosis in adults. Quality Standard 79. NICE, 2015. Available at: www.nice.org.uk/qs79
  20. NICE. Idiopathic pulmonary fibrosis in adults: diagnosis and management. Clinical Guideline 163. NICE, 2013 (last updated 2017). Available at: www.nice.org.uk/cg163